 patients
enrolled into the Vascular Quality Initiative Varicose
Vein registry, with symptomatic C2 disease, who underwent saphenous ablation with RFA or EVLT; 59.9%
also had concomitant phlebectomies. An improvement in overall symptoms at more than 3 months
follow-up was experienced by 94.4% of patients with
more signiÔ¨Åcant decreases among patients undergoing ablation and phleb